CBD May Normalize Brain Chemistry After Drinking in People with Alcohol Use Disorder
CBD had no overall effect on brain neurometabolites in people with alcohol use disorder, but specifically normalized glutathione, glutamate, and GABA levels in participants who had consumed alcohol the day before.
Quick Facts
What This Study Found
In 22 participants with AUD receiving 800 mg CBD or placebo in a crossover trial, no overall treatment effects on neurometabolites were found. However, CBD sessions showed significantly higher glutathione (p<0.001), glutamate/glutamine (p=0.001), and GABA (p=0.002) concentrations specifically for participants who had consumed alcohol the previous day, with no effect in abstinent participants.
Key Numbers
22 participants, 800 mg CBD per day, crossover design. GSH (p<0.001), GLx (p=0.001), and GABA (p=0.002) all significantly higher during CBD sessions for participants who drank the previous day. No effects in abstinent participants.
How They Did This
Crossover double-blind randomized trial with 22 non-treatment-seeking AUD participants receiving 800 mg CBD or matched placebo. Neurometabolites measured in the dorsal anterior cingulate cortex using proton magnetic resonance spectroscopy (1H-MRS).
Why This Research Matters
Alcohol disrupts brain neurochemistry, and finding that CBD selectively normalizes these disruptions after drinking sessions could position CBD as an adjunct treatment for alcohol use disorder.
The Bigger Picture
The context-dependent nature of CBD effects (only working after alcohol exposure) aligns with preclinical evidence that CBD is neuroprotective specifically against alcohol-induced damage rather than broadly altering brain chemistry.
What This Study Doesn't Tell Us
Very small sample (n=22). Non-treatment-seeking participants may not represent clinical AUD patients. Post hoc subgroup analysis by recent alcohol use was exploratory. Single dose level tested. Short treatment duration.
Questions This Raises
- ?Would longer CBD treatment show cumulative neurometabolite effects?
- ?Could CBD maintain these neurometabolite normalizations in treatment-seeking AUD patients?
Trust & Context
- Key Stat:
- CBD normalized three key brain chemicals specifically after alcohol exposure, with no effect during abstinence
- Evidence Grade:
- Double-blind crossover RCT design is strong, but very small sample and post hoc subgroup analysis reduce confidence in the specific findings.
- Study Age:
- 2025 publication.
- Original Title:
- The effect of cannabidiol on neurometabolite levels in alcohol use disorder.
- Published In:
- Alcohol and alcoholism (Oxford, Oxfordshire), 60(4) (2025)
- Authors:
- Hurzeler, Tristan(2), DeMayo, Marelyna, Logge, Warren(2), Watt, Joshua, McGregor, Iain S, Suraev, Anastasia, Haber, Paul, Morley, Kirsten
- Database ID:
- RTHC-06701
Evidence Hierarchy
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-06701APA
Hurzeler, Tristan; DeMayo, Marelyna; Logge, Warren; Watt, Joshua; McGregor, Iain S; Suraev, Anastasia; Haber, Paul; Morley, Kirsten. (2025). The effect of cannabidiol on neurometabolite levels in alcohol use disorder.. Alcohol and alcoholism (Oxford, Oxfordshire), 60(4). https://doi.org/10.1093/alcalc/agaf029
MLA
Hurzeler, Tristan, et al. "The effect of cannabidiol on neurometabolite levels in alcohol use disorder.." Alcohol and alcoholism (Oxford, 2025. https://doi.org/10.1093/alcalc/agaf029
RethinkTHC
RethinkTHC Research Database. "The effect of cannabidiol on neurometabolite levels in alcoh..." RTHC-06701. Retrieved from https://rethinkthc.com/research/hurzeler-2025-the-effect-of-cannabidiol
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.